Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (pT3) prostate cancer after radical retropubic prostatectomy

By Hawkins C.A.   Bergstralh E.J.   Lieber M.M.   Zincke H.  

Urology, Vol. 46, Iss. 3, 1995-09 ,pp. : 356-364

Elsevier

Access to resources Recommend Favorite

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

By Fakih M.   Johnson C.S.   Trump D.L.  

Urology, Vol. 60, Iss. 4, 2002-10 ,pp. : 553-561

Elsevier

Access to resources Recommend Favorite

Pilot attempt of advanced prostate cancer treatment T3NxMx−1 by intermittent more complete androgen blockade

By Dutkiewicz Slawomir  

International Urology and Nephrology, Vol. 36, Iss. 3, 2004-09 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up after triple treatment of prostate cancer stage pT3

By Schelin Sonny   Madsen Mikael   Palmqvist Elisabeth   Makela Erik   Klintenberg Claes   Aus Gunnar  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 3, 2009-04 ,pp. : 186-191

Informa Healthcare

Access to resources Recommend Favorite

Gynecomastia in patients with prostate cancer: a review of treatment options

By McLeod D.G.   Iversen P.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 713-720

Elsevier

Access to resources Recommend Favorite